Gary Novack presents posters at ARVO 2022 in Denver
Dr. Gary Novack presented two posters at the May 2022 ARVO conference in Denver. One of these was presented in the Cornea section on preclinical data on a new investigative potential treatment for dry eye disease. The other was presented in the retina section on Phase 3 studies of a new topical anesthetic for use […]
60 products!
With a recent product approval, Dr. Novack has now made substantial contributions to 60 approved products during his career…
PharmaLogic to provide service to Zhaoke Ophthalmology
PharmaLogic Development, Inc. has been contracted to provide service to Zhaoke Ophthalmology Limited in their ophthalmic product development…
Value of medical writers discussed in top journal
In a recent article in JAMA Oncology on the use of surrogate endpoints in oncology, del Paggio et al identified industry funding for nearly all. They further highlighted the use of medical writers in papers published on this work to be of concern…
Client publishes 100th paper – PharmaLogic wrote the first one
Glaukos announced that 200 papers published on their glaucoma product, the iStent. . We’re pleased to say that Dr. Novack was the medical writer for lead authors Dr. Thomas Samuelson and L. Jay Katz on the first one, in Ophthalmology…
Dr. Novack’s paper among top 100 glaucoma papers
The American Glaucoma Society recently sought to identify 100 articles with significant impact on the clinical care of patients with glaucoma. This was based upon citation frequency and the input of members of the Society…
Unintended consequences of off-label use
The American Academy of Ophthalmology reported (June 2021) a shortage of bevacizumab as used off-label, aliquoted, for ophthalmic indications in the U.S. The issue surrounding off-label and compounding pharmacy use, particularly with this class of products, were discussed in a recent editorial by Dr. Novack…
Off-label use: Article in the American Journal of Ophthalmology
Together with UC Davis Ophthalmology faculty member, Ala Moshiri, M.D., Ph.D., I published a commentary in the American Journal of Ophthalmology regarding the challenges to making off-label use of products a standard of care in retina therapies in ophthalmology…
PharmaLogic work contributes to glaucoma therapeutics
The American Academy of Ophthalmology recently updated its Glaucoma Practice Pattern. In this document, also published in the AAO’s Journal Ophthalmology, the Committee, headed by Steven J. Gedde, M.D., glaucoma is defined as a chronic, progressive optic neuropathy…
UCSC Foundation honors Gary Novack
Gary Novack was honored by the UC Santa Cruz Foundation, an organization of which he is a past president. Together with past Executive Director Ann McCrow and past president Gordon Ringold, ten year ago he helped to execute the Board Opportunity Fund…